Article Information
vol. 2 no. 16
- Received September 20, 2016
- Revision received May 26, 2017
- Accepted September 20, 2017
- .
Author Information
- Marine Bretou1,*,
- Pablo J. Sáez1,2,3,†,
- Doriane Sanséau1,†,
- Mathieu Maurin1,†,
- Danielle Lankar1,
- Melanie Chabaud1,
- Carmine Spampanato4,
- Odile Malbec1,
- Lucie Barbier2,3,5,
- Shmuel Muallem6,
- Paolo Maiuri2,3,7,8,
- Andrea Ballabio4,9,10,
- Julie Helft1,
- Matthieu Piel2,3,
- Pablo Vargas1,2,3,*,‡ and
- Ana-Maria Lennon-Duménil1,*,‡
- 1INSERM U932 Immunité et Cancer, Institut Curie, Paris Sciences & Lettres Research University, F-75248 Paris, Cedex 05, France.
- 2Institut Curie, Paris Sciences & Lettres Research University, CNRS, UMR 144, F-75005 Paris, France.
- 3Institut Pierre-Gilles de Gennes, Paris Sciences & Lettres Research University, F-75005 Paris, France.
- 4Telethon Institute of Genetics and Medicine (TIGEM), I-80078 Pozzuoli, Naples, Italy.
- 5Université Paris-Sud, Université Paris-Saclay, F-91405 Orsay, France.
- 6Epithelial Signaling and Transport Section, Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA.
- 7Institute FIRC (Italian Foundation for Cancer Research) of Molecular Oncology (IFOM-FIRC), I-20139 Milano, Italy.
- 8Istituto di Genetica Molecolare–Consiglio Nazionale delle Ricerche (IGM-CNR), Via Abbiategrasso 207, I-27100 Pavia, Italy.
- 9Medical Genetics, Department of Translational Medicine, Federico II University, I-80131 Naples, Italy.
- 10Department of Molecular and Human Genetics, Baylor College of Medicine and Jan and Dan Duncan Neurological Research Institute, Texas Children’s Hospital, Houston, TX 77030, USA.
- ↵*Corresponding author. Email: marine.bretou{at}curie.fr (M.B.); pablo.vargas{at}curie.fr (P.V.); amlennon{at}curie.fr (A.-M.L.-D.)